Connect with us
Faes Farma is expanding its Vizcaya investment from €150 million to €200 million. The new Derio plant, ready to start in early 2025 pending Aemps authorization,...
Faes Farma forecasts a double-digit growth in Latin America and plans to expand its medical visit, animal nutrition, and health businesses. The Spanish pharmaceutical company aims...
Oryzon Genomics reduces losses by 20.7% in 2023, reporting over 3.3 million euros compared to the previous year's 4.2 million. Income falls by nearly 28%, standing...
Grifols and Pharma Mar reduced profits, while Reig Jofre, Faes Farma, Rovi and Almirall increased their profits between January and June. This last company has exceeded...